Assuming mid-Dec payment, this is trading at a reasonable gross/annualised spread of 4.9%/12.6%. Also run a ruler over other NZ peers such as Ryman Healthcare, Oceania Healthcare, and Summerset .
What is covered in the Full Insight:
Introduction to Stonepeak's Offer
Key Financial Details and Valuation
Regulatory Approvals and Timeline
Shareholder Voting and Support
Conclusion and Trade Considerations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.